Biological Synthesis of 6-Aminocaproic Acid and Transgenic Microorganism Therefor

US2016257976A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016257976-A1
Application numberUS-201414889543-A
CountryUS
Kind codeA1
Filing dateMay 2, 2014
Priority dateMay 6, 2013
Publication dateSep 8, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method for preparing a recombinant microorganism simultaneously comprising genes encoding enzymes used in the biosynthesis pathway of 6-aminocaproic acid, which is a precursor of caprolactam, biosynthesizing 6-aminocaproic acid from the microorganism, and producing the same so as to synthesize caprolactam.

First claim

Opening claim text (preview).

1 . A method for preparing 6-aminocaproic acid comprising: preparing an expression vector comprising HpaI (4-hydroxy-2-oxoheptane-1,7-dioate aldolase)-HpaH (2-oxohept-3-ene-1,7-dioate dehydratase) gene, nemA (N-ethylmaleimide reductase) gene, and KIVD (alpha-ketoisovalerate decarboxylase) gene; and at least one of PdAT (beta-alanine-pyruvate transaminase) gene and BcAT (adenosylmethionine-8-amino-7-oxononanoate aminotransferase) gene (step 1); and transforming the expression vector of step 1 into a microorganism (step 2). 2 . The method of claim 1 , wherein the HpaI-HpaH gene comprises a polynucleotide represented by SEQ ID NO: 3 encoding aldolase-dehydratase. 3 . The method of claim 1 , wherein the nemA gene comprises a polynucleotide represented by SEQ ID NO: 4 encoding reductase. 4 . The method of claim 1 , wherein the KIVD (alpha-ketoisovalerate decarboxylase) gene comprises a polynucleotide represented by SEQ ID NO: 5 encoding decarboxylase. 5 . The method of claim 1 , wherein the PdAT (beta-alanine-pyruvate transaminase) gene comprises a polynucleotide represented by SEQ ID NO: 6 encoding transaminase. 6 . The method of claim 1 , wherein BcAT (adenosylmethionine-8-amino-7-oxononanoate aminotransferase) gene comprises a polynucleotide represented by SEQ ID NO: 7 encoding transaminase. 7 . The method of claim 1 , wherein the expression vector of step 1 further comprises nucleic acid (polynucleotide) sequences encoding GST, MBP, NusA, thioredoxin, ubiquitin, FLAG, BAP, 6H15, STREP, CBP, CBD, or S-tag affinity tag. 8 . The method of claim 1 , wherein the expression vector of step 1 further comprises nucleic acid sequences encoding kex2p in yeasts, purine in mammals, Factor Xa, enterokinase, subtilisin, tobacco etch virus protease, thrombin, or ubiquitin hydrolase. 9 . The method of claim 1 , wherein the microorganism of step 2 is a bacterium, yeast, or fungus. 10 . The method of claim 1 , wherein the method further comprises producing and secreting 6-aminocaproic acid by culturing the transformed microorganism of step 2 in a fed-batch fermentation. 11 . The method of claim 10 , wherein the method further comprises purifying protein secreted. 12 . An expression vector for biosynthesis of 6-aminocaproic acid comprising HpaI-HpaH gene, nemA gene, KIVD (alpha-ketoisovalerate decarboxylase) gene; and at least one of PdAT (beta-alanine-pyruvate transaminase) gene and BcAT (adenosylmethionine-8-amino-7-oxononanoate aminotransferase) gene. 13 . The expression vector of claim 12 , wherein the expression vector is pACYCWG shown in FIG. 2 . 14 . A transformant which is transformed with the expression vector of claim 12 . 15 . The transformant of claim 14 , wherein the transformant is a bacterium, yeast, or fungus. 16 . The transformant of claim 14 , wherein the transformant transforms pyruvate and/or succinic semialdehyde (SSA) into 6-aminocaproic acid. 17 . A method for producing caprolactam further comprises transforming 6-aminocaproic acid produced by the method according to claim 1 into caprolactam.

Assignees

Inventors

Classifications

  • Nitrogen as only ring hetero atom · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • Lyases (4.) · CPC title

  • transferring nitrogenous groups (2.6) · CPC title

  • transferring groups other than amino-acyl groups (2.3.1) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016257976A1 cover?
The present invention relates to a method for preparing a recombinant microorganism simultaneously comprising genes encoding enzymes used in the biosynthesis pathway of 6-aminocaproic acid, which is a precursor of caprolactam, biosynthesizing 6-aminocaproic acid from the microorganism, and producing the same so as to synthesize caprolactam.
Who is the assignee on this patent?
Korea Res Inst Bioscience & Biotechnology
What technology area does this patent fall under?
Primary CPC classification C12P13/005. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Sep 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).